Jian-ang Li
Zhongshan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
ASO Visual Abstract: In Situ Anterior Approach to Dissect the Superior Mesenteric Artery in Minimally Invasive Pancreaticoduodenectomy: Step-by-Step Technique and Video.
Journal: Annals of surgical oncology
Published: July 08, 2026
Angiogenesis and the corresponding antiangiogenic therapy in gastroenteropancreatic neuroendocrine neoplasms.
Journal: Seminars in oncology
Published: January 23, 2026
In Situ Anterior Approach to Dissect the Superior Mesenteric Artery in Minimally Invasive Pancreaticoduodenectomy: Step-by-Step Technique and Video.
Journal: Annals of surgical oncology
Published: October 22, 2025
Construction of S100 family members prognosis prediction model and analysis of immune microenvironment landscape at single-cell level in pancreatic adenocarcinoma: a tumor marker prognostic study.
Journal: International journal of surgery (London, England)
Published: October 16, 2023
Biological and clinical implications of early-onset cancers: A unique subtype.
Journal: Critical reviews in oncology/hematology
Published: June 21, 2023
Gene expression profiling reveals the genomic changes caused by MLN4924 and the sensitizing effects of NAPEPLD knockdown in pancreatic cancer.
Journal: Cell cycle (Georgetown, Tex.)
Published: December 07, 2021
Upregulated circRNA hsa_circ_0071036 promotes tumourigenesis of pancreatic cancer by sponging miR-489 and predicts unfavorable characteristics and prognosis.
Journal: Cell cycle (Georgetown, Tex.)
Published: January 28, 2021
Aberration of ARID1A Is Associated With the Tumorigenesis and Prognosis of Sporadic Nonfunctional Pancreatic Neuroendocrine Tumors.
Journal: Pancreas
Published: April 14, 2020
DIAPH3 promotes pancreatic cancer progression by activating selenoprotein TrxR1-mediated antioxidant effects.
Journal: Journal of cellular and molecular medicine
Published: December 22, 2019
Author Correction: PRMT1 promotes pancreatic cancer growth and predicts poor prognosis.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: December 04, 2019
PRMT1 promotes pancreatic cancer growth and predicts poor prognosis.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: February 18, 2019
Last Updated: 09/26/2026